A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/22 (2006.01) A61K 31/221 (2006.01) A61K 47/10 (2006.01) A61K 47/12 (2006.01)
Patent
CA 2390047
The preparation of an improved galenic delivery form of valnemulin, which is notable for its good tolerance and stability in storage, is described. The new delivery form in question is a non- aqueous or oily injection formulation, which is obtainable by means of in situ preparation and subsequent stabilisation of the free, relatively unstable base of the active ingredient. A further aspect of the present invention concerns the usage of such an injection formulation in a method of treating infectious diseases in productive livestock or domestic animals.
L'invention concerne la préparation d'une forme galénique améliorée pour l'administration de valnemulin, remarquable pour sa bonne tolérance et sa stabilité de conservation. Cette nouvelle forme d'administration est une formulation à injecter non aqueuse ou huileuse, pouvant être obtenue via une préparation in situ et la stabilisation ultérieure de la base relativement instable et libre du principe actif. Un autre aspect de l'invention concerne l'utilisation d'une telle formulation à injecter dans un traitement de maladies infectieuses du bétail ou chez les animaux domestiques.
Koller Kurt
Schwarz Franz
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Valnemulin formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Valnemulin formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Valnemulin formulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1354356